Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-12-24 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
关于辰光医疗2024年第三次临时股东大会之法律意见书
Regulatory Filings
2024-12-24 Chinese
第五届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 15th meeting of the 5th Board of Directors of Shanghai Chunguang Medical Technology Co., Ltd. It details the meeting's attendance, agenda items, voting results, and decisions made, including capital injection and amendments to subsidiary company articles of association. The content focuses on board meeting decisions and governance matters rather than financial results, audit reports, or shareholder voting outcomes. It is not a full annual or interim report, nor a regulatory filing or earnings release. The document fits the category of Board/Management Information (MANG) as it announces board meeting resolutions and related governance decisions.
2024-12-17 Chinese
关于取得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of an invention patent certificate. It details the patent name, number, application date, and the technological significance of the patent. There is no financial data, regulatory filing, or report content such as annual or quarterly financial results. The document is a formal announcement about intellectual property rights, not a financial or governance report. Therefore, it does not fit into categories like Annual Report, Interim Report, or Regulatory Filings related to financial or corporate governance. The best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-12-17 Chinese
第五届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the fifth Supervisory Board of Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting's time, place, attendance, and the voting results on a specific agenda item regarding the delay of some fundraising projects. The document does not contain financial statements or detailed financial data but serves as an official disclosure of board meeting decisions. It is not an annual report, audit report, earnings release, or any financial report. It is also not a regulatory filing or certification. The content fits best with Board/Management Information (MANG), which covers announcements of company board or management decisions and changes. The document length is short and focused on meeting resolutions, consistent with MANG filings.
2024-12-05 Chinese
第五届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 14th meeting of the 5th Board of Directors of Shanghai Chenguang Medical Technology Co., Ltd. It details meeting attendance, agenda items, voting results, and references to other announcements on the official exchange platform. The content focuses on board meeting decisions, including project delays, credit applications, and scheduling a shareholders meeting. There is no financial data, earnings information, or detailed report content. The document is not a full report but an official announcement of board meeting resolutions. Therefore, it fits best under 'Board/Management Information' (MANG), which covers announcements of changes or decisions by the board or senior management.
2024-12-05 Chinese
海通证券股份有限公司关于上海辰光医疗科技股份有限公司部分募投项目延期的核查意见
Regulatory Filings
2024-12-05 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.